CASI Pharmaceuticals, Inc 20-F for FY2022
CASI Pharmaceuticals, Inc. (CASIF)
20-F
2023-04-26
For: 2022-12-31
View Original
Added on
April 12, 2026
About this 20-F
CASI Pharmaceuticals, Inc filed this 20-F on April 26, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $43.11M
- up 42.9% from $30.17M a year earlier
- Net loss
- $41.01M
- compared with a net loss of $36.65M a year earlier
- Diluted EPS
- -$3.01
- compared with -$2.69 a year earlier